BiBo Pharma: A Global CDMO Leading in Advanced Biopharmaceutical Manufacturing Technologies April 27, 2025
Perseverance Prevails: BiBo Pharma Celebrates One-Year Anniversary of Successful First-Run 30,000L Production Line April 18, 2025
Bibo Celebrates the Spring Festival with a Promising Start! Successful Delivery of the First 30,000 Liters in 2025 March 6, 2025
Breaking news | BiBo starts construction of the world’s first 30,000-liter large-scale mammalian cell production line BiBo Lingang Phase II (P03) project rendering August 18, 2021
BiBo Milestone | 147 days of speed and passion: the first fully integrated biopharmaceutical GMP production platform in China – BiBo Biotech Lingang Phase I Project (P02) was officially delivered May 23, 2021
Endotoxin Control in the Process Development Lab: From Upstream Bacterial Fermentation to Downstream Purification Processes January 26, 2026
An assessment of eco-friendly surfactants to replace Triton™ X-100 during the process of cell lysis and their impact on the primary capture of a therapeutic protein. November 6, 2025
Endotoxin control in the process development lab: from upstream bacterial fermentation to downstream purification processes November 14, 2024
Ultra-Large Scale Biomanufacturing Empowered by Efficient Technology Transfer and PanFlex® System June 3, 2024
Characterization Of Oxygen Mass Transfer Rate (KLa) Using A Statistical Design Of Experiment (DoE) For Bioreactor Scale-Up May 29, 2024
Strategies to Accelerate Process Development from Preclinical to Manufacturing for Gene Therapy May 29, 2024
Strategies to Accelerate Process Development from Preclinical to Manufacturing for Gene Therapy Download »
Characterization Of Oxygen Mass Transfer Rate (KLa) Using A Statistical Design Of Experiment (DoE) For Bioreactor Scale-Up Download »
A Comparative Study to Evaluate Different Analytical Methods Used to Quantify a Fusion Protein and Two Types of IgG Molecules Produced in CHO Cell Line Download »
